14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 SYRS stock ended at $5.08. This is 0.97% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.56% from a day low at $5.07 to a day high of $5.20.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Syros Pharmaceuticals prices

Date Open High Low Close Volume
May 06, 2024 $5.17 $5.20 $5.07 $5.08 36 782
May 03, 2024 $5.15 $5.34 $5.05 $5.13 54 354
May 02, 2024 $5.53 $5.64 $5.19 $5.20 301 204
May 01, 2024 $5.29 $5.65 $5.28 $5.44 199 558
Apr 30, 2024 $5.29 $5.43 $5.23 $5.40 94 471
Apr 29, 2024 $5.08 $5.46 $5.05 $5.38 113 591
Apr 26, 2024 $5.03 $5.12 $4.99 $5.04 44 487
Apr 25, 2024 $4.94 $5.15 $4.92 $5.10 128 567
Apr 24, 2024 $5.20 $5.20 $5.00 $5.07 89 493
Apr 23, 2024 $4.98 $5.32 $4.98 $5.14 163 477
Apr 22, 2024 $4.57 $5.03 $4.57 $4.99 145 326
Apr 19, 2024 $4.67 $4.71 $4.41 $4.54 169 156
Apr 18, 2024 $5.04 $5.06 $4.72 $4.72 101 492
Apr 17, 2024 $5.55 $5.67 $5.09 $5.11 125 712
Apr 16, 2024 $5.27 $5.76 $5.18 $5.56 283 875
Apr 15, 2024 $5.34 $5.63 $5.24 $5.35 148 071
Apr 12, 2024 $5.95 $5.95 $5.33 $5.39 210 645
Apr 11, 2024 $5.58 $5.94 $5.48 $5.92 258 086
Apr 10, 2024 $5.44 $5.62 $5.21 $5.53 238 186
Apr 09, 2024 $4.74 $5.84 $4.72 $5.50 964 278
Apr 08, 2024 $4.66 $4.70 $4.50 $4.50 154 108
Apr 05, 2024 $4.82 $4.84 $4.66 $4.67 128 971
Apr 04, 2024 $5.00 $5.17 $4.75 $4.82 272 121
Apr 03, 2024 $4.63 $5.03 $4.63 $4.98 386 778
Apr 02, 2024 $5.02 $5.02 $4.55 $4.64 340 312
Click to get the best stock tips daily for free!

About Syros Pharmaceuticals

Syros Pharmaceuticals Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acu... SYRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT